HomeAKTX • NASDAQ
add
Akari Therapeutics PLC
Previous close
$2.12
Day range
$2.12 - $2.24
Year range
$1.08 - $5.50
Market cap
16.88M USD
Avg Volume
25.13K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.99M | 30.06% |
Net income | -5.57M | -271.24% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.98M | -29.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.31M | -81.76% |
Total assets | 2.77M | -65.41% |
Total liabilities | 6.32M | 20.90% |
Total equity | -3.55M | — |
Shares outstanding | 7.92M | — |
Price to book | -4.82 | — |
Return on assets | -420.16% | — |
Return on capital | 791.78% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -5.57M | -271.24% |
Cash from operations | -4.04M | 15.52% |
Cash from investing | — | — |
Cash from financing | 1.51M | -13.56% |
Net change in cash | -2.54M | 16.46% |
Free cash flow | -2.96M | 69.43% |
About
Founded
2004
Headquarters
Website
Employees
9